🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Sweden / NCT05039203
Active, not recruiting Observational

Bacteriuria and Indwelling Urinary Catheter.

NCT05039203 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2022-05-24
Last updated
2024-11-20

Condition(s) studied

Bacteriuria AsymptomaticUrinary Tract Infections

Investigational drug(s) / intervention(s)

Indwelling urinary catheter

Indwelling urinary catheter: Removal of indwelling urinary catheter

Study summary

Investigation of 1. The incidence of symptomatic bacteriuria during four weeks after removal of an IUC in inpatients at a rehabilitation clinic for patients ≥ 65 years compared with the incidence of symptomatic bacteriuria among inpatients not treated with an IUC and 2. For how long does ABU persist in inpatients at a rehabilitation clinic for patients

≥ 65 years during a follow-up time of four weeks after IUC-removal?

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Admission to a rehabilitation clinic for patients ≥ 65 years in Stockholm County, Sweden * Ability to understand oral and written instructions in Swedish * Ability to produce a voided urine-sample Exclusion Criteria: * Severe cognitive failure and/or disability to understand oral and written instructions in Swedish according to the healthcare-personnel's judgment at the ward * End-of-life care * Physical disability to produce voided urine-samples * Ongoing antimicrobial treatment for symptomatic bacteriuria

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Geriatric Department, Södertälje Hospital Södertälje Sweden
Geriatric Department, Danderyd Hospital Stockholm Sweden

More Region Stockholm trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05039203 on ClinicalTrials.gov ↗ ← All trials in Sweden